Metformin prevents the development of monocrotaline‑induced pulmonary hypertension by decreasing serum levels of big endothelin‑1
Authors:
Open Access
- 6 October 2020
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 20 (6) , 1
Abstract
Pulmonary hypertension (PH) is a disease with poor prognosis, and it is characterized by the progressive elevation of pulmonary vascular resistance and pressure. Various factors are associated with the pathology of PH, including AMP‑activated protein kinase (AMPK) deficiency. The present study aimed to evaluate the therapeutic effect of metformin, an AMPK activator, in a monocrotaline (MCT)‑induced PH rat model. Rats were randomly divided into the following three groups: i) Saline‑injected group (sham group); ii) monocrotaline (MCT)‑injected group (PH group); iii) MCT‑injected and metformin‑treated group (MT group). Four weeks following MCT injection, cardiac ultrasonography, invasive hemodynamic measurements, measurement of serum levels of big endothelin‑1 (big ET‑1) and histological analysis were performed to evaluate the effect of metformin treatment in PH. Pulmonary arterial pressure and serum big ET‑1 concentrations were reduced in the MT group compared with the PH group. Medial wall thickness and wall area of the pulmonary arterioles in the MT group were decreased compared with the PH group. Comparing the right heart functional parameters among groups revealed that the acceleration time/ejection time ratio improved in the MT group compared with the PH group. Thus, the present study demonstrated the efficacy of metformin in an MCT‑induced PH rat model and suggested that metformin may be a valuable, potential novel therapeutic for the treatment of PH.Keywords
This publication has 52 references indexed in Scilit:
- The monocrotaline model of pulmonary hypertension in perspectiveAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Acute Effects of Vardenafil on Pulmonary Artery Responsiveness in Pulmonary HypertensionThe Scientific World Journal, 2012
- The value of tools to assess pulmonary arterial hypertensionEuropean Respiratory Review, 2011
- The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertensionPharmacological Research, 2011
- Hypoxic pulmonary vasoconstriction: mechanisms of oxygen-sensingCurrent Opinion in Anaesthesiology, 2011
- Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertensionBritish Journal of Pharmacology, 2009
- Effect of hydroalcoholic extract of Zingiber officinalis rhizomes on LPS-induced rat airway hyperreactivity and lung inflammationProstaglandins, Leukotrienes and Essential Fatty Acids, 2007
- Metformin Inhibits Cytokine-Induced Nuclear Factor κB Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial CellsHypertension, 2006
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- Doppler echocardiographic index for assessment of global right ventricular functionJournal of the American Society of Echocardiography, 1996